Invests in
Stages:
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- Uo
- Io
Lists including Nanna
Investments
Capstan Therapeutics
Total Funding: $280M
Noema Pharma
Total Funding: $110M
Inversago Pharma
Total Funding: $110M
F2G
Total Funding: $160M
Numab
Total Funding: $110M
Lava Therapeutics
Total Funding: $100M
NodThera
Total Funding: $95M
NBE-Therapeutics
Total Funding: $20M
Inthera Bioscience
Total Funding: $20M
Work Experience
2021
General Partner
2021
- General Partner, Forbion Growth Opportunities Fund - Late stage and crossover investments in biotech - Board director of Capstan, BioInvent, F2G, Noema and Inversago (acquired by Novo Nordisk), observer in Numab
2012 - 2021
Partner
2018 - 2021
• Partner in Novo Ventures • Board director in Numab, Lava (LVTX), ReViral (acquired by Pfizer), NodThera and Stargazer • Previous deals as lead investor/board director include NBE Therapeutics (acquired by Boehringer Ingelheim), Inventiva (IVA), Orphazyme (ORPHA), ObsEva (OBSV) and IO Biotech (IOBT)
Principal
2016 - 2017
• Principal in Novo Ventures
Investment Director
2013 - 2015
• Investment Director in Novo Seeds • Board member in IO Biotech, Inthera, Glionova, Affinicon, MinervaX, Pcovery, board observer in Galecto, ForEndo
Principal
2012 - 2013
• Principal in Novo Seeds • Seed stage biotech venture investment in Northern Europe
2008 - 2012
Associate
2008 - 2012
• Investment professional in a healthcare venture fund • Successful exits from both primary and secondary deals, incl Convergence, Ulthera, SureCalm • Multiple deals completed from initial diligence to closing • Various deal structures: primary/secondary investments, spin-out, start-up, management buy-in
2008 - 2008
Intern
2008 - 2008
MBA summer internship
2008 - 2008
Consulting project
2008 - 2008
MBA team consulting project: IP technology in UK healthcare
2007 - 2007
Consulting project
2007 - 2007
MBA team consulting project on business model and strategy for a biotech start-up
2005 - 2007
Senior Business Intelligence Analyst
2006 - 2007
• Business Intelligence on performance metrics across £315 M research portfolio • Strategic evaluation to CEO
Research Manager
2005 - 2006
• Financial and scientific analyses of research portfolio across organisation • Liaison with principal investigators and research organisations in UK and US
2000 - 2004
Graduate Research Associate
2000 - 2004
Research project leading to PhD thesis in development neuroscience
1996 - 1997
Marketing Manager
1996 - 1997
Managed marketing campaigns for international business conference and training group